European Archives - Page 912 of 1057 - European Medical Journal

Continue
8 Mins
28 Jul 2016

Biosimilars: Shaping the Future of Haematology

Prof Robin Foà opened the symposium by highlighting how improving healthcare and an ageing population are increasing the burden on healthcare resources…
2 Mins
28 Jul 2016

Evidence-Based Transfusion Medicine for Coagulopathy of Chronic Liver Disease

Patients with chronic liver disease variably exhibit abnormalities of coagulation related to decreased synthesis of coagulation proteins. This results in…
July 2016

EMJ Hematology 4.1 2016

Welcome to EMJ Hematology. This edition provides a wide selection of peer-reviewed articles exploring the emerging issues in haematology…
12 Mins
28 Jul 2016

Review of the 21st European Hematology Association Congress 2016

The city of Copenhagen has been voted the go-to place for holiday makers in Denmark, and from the 9th of June and the 4 days that followed, it was…
9 Mins
28 Jul 2016

Advances in the Treatment of Non-Hodgkin’s Lymphoma: Exploring New Frontiers

A recent symposium at the European Hematology Association (EHA) congress, chaired by Prof Eva Kimby, explored the changing paradigms in the treatment of…
2 Mins
28 Jul 2016

Management of Superficial Vein Thrombosis

Superficial vein thrombosis (SVT), indicating thrombosis of the superficial vein system, is less well-studied than deep vein thrombosis (DVT) because it…
2 Mins
28 Jul 2016

GBT440, a Novel Sickle Haemoglobin Polymerisation Inhibitor, Increases Haemoglobin Oxygen Affinity and Results in a Rapid Improvement in Haemolysis and Anaemia

GBT440 is a novel, small molecule haemoglobin oxygen affinity modifier. In vitro data has shown that by increasing sickle haemoglobin (HbS) oxygen…
8 Mins
28 Jul 2016

New Insights in Bone Marrow Failure

Several rare haematological diseases are linked to bone marrow failure (BMF). This symposium provided the latest scientific insights into the different…
2 Mins
28 Jul 2016

Role of the Calreticulin Gene and Its Deregulation in Myeloproliferative Neoplasms

Polycythaemia vera (PV), essential thrombocythaemia (ET), and primary myelofibrosis (PMF) are the three classical Philadelphia chromosome-negative…
9 Mins
28 Jul 2016

Navigating the Changing Multiple Myeloma Treatment Landscape

The treatment landscape for patients with multiple myeloma (MM) is constantly evolving. Over the past decade, the introduction of novel agents including…